Nagase H, Takagahara S, Satomi Y, Ando A, Kubo K, Ikeda S. Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development. J Pharm Pharm Sci [Internet]. 2021 Feb. 17 [cited 2024 Jul. 14];24:71-83. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31389